# A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis

> **NCT02081183** · PHASE3 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 16 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mycophenolate mofetil (MMF)
- **DRUG:** Cyclophosphamide, Maintenance Phase
- **DRUG:** Cyclophosphamide, Induction Phase
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT02081183
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02081183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02081183, "A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02081183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*